Ramipril contraindications: Difference between revisions

Jump to navigation Jump to search
Gerald Chi- (talk | contribs)
m Changed protection level for "Ramipril contraindications" ([Edit=Allow only autoconfirmed users] (expires 16:22, 4 March 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 16:22, 4 March 2014 (UTC)))
Amr Marawan (talk | contribs)
No edit summary
Line 1: Line 1:
{{CMG}}
__NOTOC__
 
{{Ramipril}}
 
{{CMG}}; {{AE}} {{AM}}
[[Hypersensitivity]] to [[ACE inhibitor]]s (particularly history of [[angioedema]]).


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher =  | date =  | accessdate = }}</ref>




==References==
{{Reflist}}


{{FDA}}
{{FDA}}


[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 16:25, 18 February 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

For patient information about Ramipril, click here.

Ramipril

Overview

Ramipril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

Category

Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [5]

[1]


References

  1. "ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]".

Adapted from the FDA Package Insert.